Sam Greenhouse: his contributions as a consultant to the Food and Drug Administration.
This paper recounts contributions made by Sam Greenhouse to the Food and Drug Administration during his tenure as an advisory committee member and as chair of the committee. The events and topics are taken from available recollections and minutes and selectively describe a range of topic areas and issues about which Sam Greenhouse played a substantial leadership role. Published in 2003 by John Wiley & Sons, Ltd.
O'Neill
Robert T
RT
Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Room 15B45, 5600 Fishers Lane, Rockville, MD 20857, USA. Oneill@cder.fda.gov
D026683:Advisory Committees / Q000266:history; D001699:Biometry / Q000266:history; D002986:Clinical Trials as Topic / Q000266:history*; D003253:Consultants / Q000266:history; D017277:Drug Approval / Q000266:history*; D049673:History, 20th Century; D006801:Humans; D007857:Leadership; D014481:United States; D014486:United States Food and Drug Administration / Q000266:history*